When it Comes to Treating Ulcerative Colitis, US Gastroenterologists May be Betting it All on JAK…
November 30, 2023 10:59 ET
|
Spherix Global Insights
Exton, Pennsylvania, Nov. 30, 2023 (GLOBE NEWSWIRE) -- With the Ulcerative Colitis (UC) market set to heat up in the coming months, the JAK class seems poised to become a dominant treatment,...
Global WholeHealth Partners Corp (OTC: GWHP) to Announce that Global is Now Offering All 4 Major Vaccines (AstraZeneca, J&J, Pfizer, Moderna) as Mentioned in 8k Filings 03/08/21, 06/09/21, 06/15/21, and 06/24/21
August 09, 2021 07:00 ET
|
Global WholeHealth Partners Corp.
The Vaccines Have Been Verified to Assist in the Protection Against the Delta Variant SAN CLEMENTE, CA, Aug. 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Global WholeHealth Partners Corp...
Arch Biopartners Files New Patent Application for Novel Antibody Candidates Targeting DPEP-1 Mediated Organ Inflammation
June 10, 2021 07:20 ET
|
Arch Biopartners
TORONTO, June 10, 2021 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company developing new drug candidates for treating...
UPDATE -- Dyadic Advancing Proprietary Owned COVID-19 vaccine candidate, DYAI-100, Towards Human Clinical Trial
March 29, 2021 08:30 ET
|
Dyadic International, Inc.
Advancing Dyadic’s proprietary owned COVID-19 vaccine candidate, DYAI-100, towards first-in-human Phase 1 clinical trial Engaged CR2O, a contract research organization, to manage and support further...
RenovaCare to Present at BioNJ/JP Morgan/J&J BioPartnering Conference
September 15, 2020 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., Sept. 15, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...
Johnson & Johnson's Biosense Webster’s MaryAnn Edzards Joins BioSig
December 19, 2018 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Dec. 19, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Appoints Johnson & Johnson Veteran Amy Scott
August 20, 2018 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Aug. 20, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
Johnson & Johnson Veteran Chuck Austin To Scale Up BioSig Operations
January 09, 2018 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Jan. 09, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
Agile Therapeutics to Present at the 15th Annual Needham Healthcare Conference
March 30, 2016 16:10 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 30, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Agile Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results
March 09, 2016 16:10 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 09, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of...